Overview

A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
This is a clinical trial assessing duloxetine and comparator to placebo in patients who have generalized anxiety disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Boehringer Ingelheim
Treatments:
Duloxetine Hydrochloride
Venlafaxine Hydrochloride